NK cells were stimulated with K562, Nalm-6 target cells and ALL and CLL cells from patients, according to the protocol described in Section “Materials and Methods.” K562 target cells were used as an internal control, as they do not express CD19 on their surface. Here, CD19 is linked to B-cell chronic lymphocytic leukemia.